Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$11.4M
+122.5% from 2023
Prescriptions
2,939
$3,880.81 per claim
Patients
410
257 prescribers
Total spending, 2024
$11.4M
$27,818.76 per patient
Medicare prescription drug plans paid $11.4M for Trazimera in 2024, for 2,939 prescriptions and refills to 410 patients (up 122.5% from 2023). The average cost per claim was $3,880.81.
California had the highest Medicare cost for Trazimera in 2024: $2.4M for 659 claims, followed by Alabama ($1.6M).
Heather White, hematology-oncology in Greenville, NC, had the highest Medicare cost for Trazimera in 2024: 99 claims costing $375K.
Trazimera is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Heather White Greenville, NC | Hematology-Oncology | 99 | Under 11 | $375K |
| Sejal N Vaidya Silver Spring, MD | Nurse Practitioner | 69 | 24 | $301K |
| Diane D Wilder |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 83 | 662 | 115 | $2.9M |
| 2023 | 136 | 1,147 | 174 | $5.1M |
| 2024 | 257 | 2,939 | 410 | $11.4M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Medical Oncology |
| 66 |
| 11 |
| $290K |
| Wei Wang San Francisco, CA | Medical Oncology | 61 | Under 11 | $220K |
| Alejandro Garcia Tuscaloosa, AL | Hematology-Oncology | 41 | Under 11 | $218K |
| Ashvini Sengar Gadsden, AL | Hematology-Oncology | 52 | Under 11 | $185K |
| Michael S McAllister Dothan, AL | Hematology-Oncology | 36 | Under 11 | $153K |
| Mohamed M Haq Houston, TX | Hematology-Oncology | 48 | Under 11 | $149K |
| Christine G Simone Stuart, FL | Hematology-Oncology | 24 | Under 11 | $148K |
| Keith Lerro Wilson, NC | Hematology-Oncology | 34 | Under 11 | $144K |
| Andrew Briggler Little Rock, AR | Hematology-Oncology | 34 | Under 11 | $144K |
| Marshall T Schreeder Huntsville, AL | Hematology-Oncology | 30 | Under 11 | $129K |
| Kavita B Kalra Baltimore, MD | Hematology-Oncology | 17 | Under 11 | $129K |
| Laxmi S Iyer Riverside, CA | Hematology-Oncology | 35 | Under 11 | $126K |
| Heather R Shah Decatur, AL | Hematology-Oncology | 38 | Under 11 | $126K |
| Arnold K Yee Honolulu, HI | Medical Oncology | 30 | Under 11 | $125K |
| Krisztina I Larson Burbank, CA | Hematology-Oncology | 34 | Under 11 | $124K |
| Zili He X Flushing, NY | Hematology-Oncology | 42 | Under 11 | $122K |
| Martin Palmeri Asheville, NC | Hematology-Oncology | 28 | Under 11 | $122K |
| Arindam Bagchi Columbia, MO | Hematology-Oncology | 23 | Under 11 | $119K |
| Ovidiu G Negrea Boone, NC | Hematology-Oncology | 32 | Under 11 | $113K |
| Daniel M Schreeder Huntsville, AL | Hematology-Oncology | 42 | Under 11 | $108K |
| Thomas B Sneed Little Rock, AR | Hematology-Oncology | 28 | Under 11 | $107K |
| Gregory L Ortega Orange City, FL | Hematology-Oncology | 23 | Under 11 | $106K |
| Melvin P Palalay Honolulu, HI | Hematology-Oncology | 31 | Under 11 | $104K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Pfizer US Pharm PFE | 2,939 | $11.4M |